Louise Park Stejbach brings more than 30 years of biopharma commercialization and brand strategy experience to her role as commercial advisor.  Since 2008, Louise has advised on pre-launch and launch planning, market assessment and prioritization, target product profile development, and go-to-market plans for several pre-commercial and first commercial biotech firms as well as established biopharmaceutical companies, vaccine manufacturers, and other healthcare clients.  Prior to consulting, Ms. Stejbach spent 18 years at Merck where she developed deep experience in commercial (HCP, payer, patient) strategy and execution across many therapeutic categories and stages of the lifecycle and held US leadership roles as both the Vice President of Marketing for Diabetes and the Vice President of Osteoporosis Marketing and Specialty Sales.  Louise has an MBA (University of Chicago) and a BS in Chemical Engineering (University of Virginia).